MedTrace Logo

Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"

NCT00418353 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-01-04

No results posted yet for this study

Summary

Antenatal corticosteroids result in substantial decrease in neonatal morbidity and mortality by specifically reducing the risk of respiratory distress syndrome, intraventricular hemorrhage and neonatal death among premature infants. No human randomized study has formally compared betamethasone and dexamethasone, the preferred corticosteroids for antenatal therapy, with regards to their effectiveness in reducing neonatal morbidities and mortality. Our objective was to compare betamethasone with dexamethasone in terms of effectiveness in reducing perinatal morbidities and mortality among preterm infants.

Conditions

  • Respiratory Distress Syndrome
  • Intraventricular Hemorrhage
  • Neonatal Mortality

Interventions

DRUG

Betamethasone(Celestone soluspan) and Dexamethasone

Sponsors & Collaborators

Principal Investigators

  • Andrew A Elimian, M.D · Stony Brook University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31
Completion
2005-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00418353 on ClinicalTrials.gov